Literature DB >> 23913653

Patterns of nodal metastasis and prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinoma.

Matthew E Spector1, K Kelly Gallagher, Emily Bellile, Steven B Chinn, Mohannad Ibrahim, Serena Byrd, Eric J Chanowski, Heather M Walline, Jeffrey S Moyer, Mark E Prince, Gregory T Wolf, Carol R Bradford, Jonathan B McHugh, Kitrina Cordell, Thomas Carey, Francis P Worden, Avraham Eisbruch, Douglas B Chepeha.   

Abstract

BACKGROUND: The current American Joint Committee on Cancer (AJCC) staging system may not accurately reflect survival in patients with human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma (SCC). The purpose of this study was to develop a system that more precisely predicts survival.
METHODS: CT scans from 156 patients who underwent chemoradiation for advanced-stage oropharyngeal SCC with >2 years follow-up were reviewed. We modeled patterns of nodal metastasis associated with different survival rates. We defined HPV+ N1 as a single node <6 cm, ipsilaterally, contralaterally, or bilaterally. HPV+ N2 was defined as a single node ≥6 cm or ≥2 nodes ipsilaterally/contralaterally or ≥3 nodes bilaterally. HPV+ N3 was defined as matted nodes.
RESULTS: There was no significant difference in disease-specific survival (DSS; p = .14) or overall survival (OS; p = .16) by AJCC classification. In patients grouped by HPV+ N1, HPV+ N2, and HPV+ N3 nodal classification, significant differences in DSS (100%, 92%, and 55%, respectively; p = .0001) and OS (100%, 96%, and 55%, respectively; p = .0001) were found.
CONCLUSION: A staging system with reclassification of size, bilaterality, and matted nodes more accurately reflects survival differences in this cohort of patients. Review of the AJCC staging system with these criteria should be considered for HPV-positive oropharyngeal SCC.
Copyright © 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  American Joint Committee on Cancer Staging System; human papillomavirus; matted nodes; nodal metastasis; oropharyngeal squamous cell carcinoma

Mesh:

Year:  2014        PMID: 23913653      PMCID: PMC4112024          DOI: 10.1002/hed.23438

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  8 in total

1.  UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line.

Authors:  Alice L Tang; Samantha J Hauff; John H Owen; Martin P Graham; Michael J Czerwinski; Jung Je Park; Heather Walline; Silvana Papagerakis; Jay Stoerker; Jonathan B McHugh; Douglas B Chepeha; Carol R Bradford; Thomas E Carey; Mark E Prince
Journal:  Head Neck       Date:  2011-12-13       Impact factor: 3.147

2.  Human papillomavirus and survival of patients with oropharyngeal cancer.

Authors:  K Kian Ang; Jonathan Harris; Richard Wheeler; Randal Weber; David I Rosenthal; Phuc Felix Nguyen-Tân; William H Westra; Christine H Chung; Richard C Jordan; Charles Lu; Harold Kim; Rita Axelrod; C Craig Silverman; Kevin P Redmond; Maura L Gillison
Journal:  N Engl J Med       Date:  2010-06-07       Impact factor: 91.245

3.  Matted nodes: poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status.

Authors:  Matthew E Spector; K Kelly Gallagher; Emily Light; Mohannad Ibrahim; Eric J Chanowski; Jeffrey S Moyer; Mark E Prince; Gregory T Wolf; Carol R Bradford; Kitrina Cordell; Jonathan B McHugh; Thomas Carey; Francis P Worden; Avraham Eisbruch; Douglas B Chepeha
Journal:  Head Neck       Date:  2012-01-13       Impact factor: 3.147

4.  Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results.

Authors:  Felix Y Feng; Hyungjin M Kim; Teresa H Lyden; Marc J Haxer; Francis P Worden; Mary Feng; Jeffrey S Moyer; Mark E Prince; Thomas E Carey; Gregory T Wolf; Carol R Bradford; Douglas B Chepeha; Avraham Eisbruch
Journal:  J Clin Oncol       Date:  2010-04-26       Impact factor: 44.544

5.  HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer.

Authors:  Jan Klozar; Vit Kratochvil; Martina Salakova; Jana Smahelova; Eva Vesela; Eva Hamsikova; Jan Betka; Ruth Tachezy
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-12-20       Impact factor: 2.503

6.  EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer.

Authors:  Bhavna Kumar; Kitrina G Cordell; Julia S Lee; Francis P Worden; Mark E Prince; Huong H Tran; Gregory T Wolf; Susan G Urba; Douglas B Chepeha; Theodoros N Teknos; Avraham Eisbruch; Christina I Tsien; Jeremy M G Taylor; Nisha J D'Silva; Kun Yang; David M Kurnit; Joshua A Bauer; Carol R Bradford; Thomas E Carey
Journal:  J Clin Oncol       Date:  2008-05-12       Impact factor: 44.544

7.  Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures.

Authors:  Felix Y Feng; Hyungjin M Kim; Teresa H Lyden; Marc J Haxer; Mary Feng; Frank P Worden; Douglas B Chepeha; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-06-07       Impact factor: 7.038

8.  A comparison of staging systems for nasopharyngeal carcinoma.

Authors:  J S Cooper; R Cohen; R E Stevens
Journal:  Cancer       Date:  1998-07-15       Impact factor: 6.860

  8 in total
  12 in total

1.  Matted nodes: High distant-metastasis risk and a potential indication for intensification of systemic therapy in human papillomavirus-related oropharyngeal cancer.

Authors:  Jeffrey M Vainshtein; Matthew E Spector; Mohannad Ibrahim; Carol R Bradford; Gregory T Wolf; Matthew H Stenmark; Francis P Worden; Jonathan B McHugh; Mark E Prince; Thomas Carey; Douglas B Chepeha; Avraham Eisbruch
Journal:  Head Neck       Date:  2015-07-15       Impact factor: 3.147

Review 2.  HPV-Associated Head and Neck Cancer: Unique Features of Epidemiology and Clinical Management.

Authors:  Jessica H Maxwell; Jennifer R Grandis; Robert L Ferris
Journal:  Annu Rev Med       Date:  2015-08-26       Impact factor: 13.739

3.  Proposed Staging System for Patients With HPV-Related Oropharyngeal Cancer Based on Nasopharyngeal Cancer N Categories.

Authors:  Kristina R Dahlstrom; Adam S Garden; William N William; Ming Yann Lim; Erich M Sturgis
Journal:  J Clin Oncol       Date:  2016-02-16       Impact factor: 44.544

4.  Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.

Authors:  Neil Gildener-Leapman; Jeehong Kim; Shira Abberbock; Garret W Choby; Rajarsi Mandal; Umamaheswar Duvvuri; Robert L Ferris; Seungwon Kim
Journal:  Head Neck       Date:  2016-05-26       Impact factor: 3.147

5.  Impact of American Joint Committee on Cancer Eighth Edition clinical stage and smoking history on oncologic outcomes in human papillomavirus-associated oropharyngeal squamous cell carcinoma.

Authors:  Peter G Hawkins; Michelle L Mierzwa; Emily Bellile; William C Jackson; Kelly M Malloy; Steven B Chinn; Matthew E Spector; Andrew G Shuman; Chaz L Stucken; Scott A McLean; Carol R Bradford; Mark E Prince; Thomas E Carey; Francis P Worden; Paul L Swiecicki; Jeremy M G Taylor; Gregory T Wolf; Avraham Eisbruch; Keith A Casper
Journal:  Head Neck       Date:  2019-02-18       Impact factor: 3.821

6.  Dual role for p16 in the metastasis process of HPV positive head and neck cancers.

Authors:  Rüveyda Dok; Mary Glorieux; Karolina Holacka; Marieke Bamps; Sandra Nuyts
Journal:  Mol Cancer       Date:  2017-06-29       Impact factor: 27.401

Review 7.  The Double-Edged Sword-How Human Papillomaviruses Interact With Immunity in Head and Neck Cancer.

Authors:  Hao-Fan Wang; Sha-Sha Wang; Ya-Jie Tang; Yu Chen; Min Zheng; Ya-Ling Tang; Xin-Hua Liang
Journal:  Front Immunol       Date:  2019-04-02       Impact factor: 7.561

8.  Value of transoral surgery for human papillomavirus-mediated oropharyngeal cancer: validation of a new staging system in Japanese patients.

Authors:  Eiko Kimura; Koji Araki; Masayuki Tomifuji; Yuya Tanaka; Kosuke Uno; Taku Yamashita; Akihiro Shiotani
Journal:  J Int Med Res       Date:  2019-09-13       Impact factor: 1.671

9.  Parotid sparing in RapidPlan Oropharynx models: To split or not to split.

Authors:  James O'Toole; Kenny Wu; Regina Bromley; Mark Stevens; Thomas Eade; Kirsten van Gysen; John Atyeo
Journal:  J Med Radiat Sci       Date:  2020-02-11

10.  Contralateral nodal failures in oropharyngeal cancers after TORS and unilateral neck management: a retrospective study.

Authors:  Axel Sahovaler; John J W Lee; Wei Xu; Susie Su; Ali Hosni; Andrew Bayley; David P Goldstein; John R de Almeida
Journal:  J Otolaryngol Head Neck Surg       Date:  2021-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.